EtoposideCapsulesBacterial CapsulesCapsule EndoscopyJoint CapsuleLens Capsule, CrystallineAntineoplastic Agents, PhytogenicCapsule EndoscopesAntineoplastic Combined Chemotherapy ProtocolsTopoisomerase II InhibitorsInternal CapsuleIfosfamideCisplatinCarcinoma, Small CellDNA Topoisomerases, Type IIPodophyllotoxinVincristineDoxorubicinCyclophosphamideCarboplatinAmsacrineDrug Administration ScheduleBleomycinLung NeoplasmsCombined Modality TherapyCytarabineAntineoplastic AgentsFungal CapsulesGerminomaBowman CapsuleAdministration, OralTeniposideSubrenal Capsule AssayNucleic Acid Synthesis InhibitorsTopoisomerase InhibitorsLeukopeniaTreatment OutcomeTransplantation, AutologousApoptosisTesticular NeoplasmsDrug Resistance, NeoplasmMitoxantroneRemission InductionNeoplasms, Germ Cell and EmbryonalInfusions, IntravenousDNA DamageHodgkin DiseasePolysaccharides, BacterialCapsule OpacificationCamptothecinDose-Response Relationship, DrugCarmustineHematologic DiseasesDrug EvaluationTumor Cells, CulturedSalvage TherapyLymphoma, Non-HodgkinTopotecanTopoisomerase I InhibitorsSurvival AnalysisDisease-Free SurvivalSurvival RatePosterior Capsule of the LensRazoxaneNeutropeniaPrednisoneDrug ResistanceThrombocytopeniaCryptococcus neoformansProcarbazineDrug Resistance, MultipleP-GlycoproteinOrganophosphorus CompoundsCell SurvivalMelphalanPaclitaxelVinblastineLens DiseasesCapsulorhexisBiological AvailabilityTime FactorsGranulocyte Colony-Stimulating FactorRetroperitoneal NeoplasmsAlopeciaDaunorubicinBone Marrow DiseasesCell Line, TumorHematopoietic Stem Cell TransplantationMethotrexateHL-60 CellsLevoleucovorinDrug SynergismNeoplasmsSmall Cell Lung CarcinomaMesnaCaspasesDrug Screening Assays, AntitumorRecurrenceLens, CrystallineDNA Topoisomerases, Type I